Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03206567 · ClinicalTrials.gov registry record · NA

Efficacy and Safety of a Nutraceutical Supplement With Standardized Botanicals in Women With Thinning Hair

A NA study of Hair Thinning, sponsored by Ablon Skin Institute Research Center.

Completed
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT03206567 is a NA study of Hair Thinning that has completed, run by Ablon Skin Institute Research Center. The registered enrollment target is 40 participants, below the 62-participant average among 10 other Hair Thinning trials with a reported enrollment target (35% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03206567, a NA study of Hair Thinning, has completed, sponsored by Ablon Skin Institute Research Center.

COMPLETED
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

NUTRAFOL® is a novel nutraceutical supplement, scientifically formulated to specifically target the multiple underlying causes of hair loss and thinning in women. It does not contain hormones, drugs, or industry by-products. The purpose of this clinical research study is to evaluate the safety, efficacy and physiological effects of NUTRAFOL® supplement compared to placebo in forty (40) female subjects, ages 21-65 years of age with self-perceived thinning hair over the course of six months of continued use.

Conditions Studied

Interventions

  • OTHER Placebo capsules
  • DIETARY_SUPPLEMENT Nutrafol Supplement capsules

Study Locations (1)

California

  • Ablon Skin Institute & Research Center - Manhattan Beach

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2017-05-04
Est. Completion 2018-03-01
Phase NA

What the Registry Record Tells You About NCT03206567

The ClinicalTrials.gov registry entry for NCT03206567 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 62-participant average among 10 other Hair Thinning trials with a reported enrollment target (35% lower). The listed sponsor is Ablon Skin Institute Research Center, which has 7 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Hair Thinning appearing as the primary indexed condition, and to 2 interventions - of which Placebo capsules is the first listed.

NCT03206567 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT03206567 about?

NCT03206567 is a clinical study titled "Efficacy and Safety of a Nutraceutical Supplement With Standardized Botanicals in Women With Thinning Hair". NUTRAFOL® is a novel nutraceutical supplement, scientifically formulated to specifically target the multiple underlying causes of hair loss and thinning in women. It does not contain hormones, drugs, or industry by-products. The purpose of this clinical research study is to evaluate the safety, eff...

What is the current status of trial NCT03206567?

This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2017-05-04. Estimated completion is 2018-03-01.

What conditions does trial NCT03206567 study?

This clinical trial studies the following conditions: Hair Thinning.

What interventions are being tested in trial NCT03206567?

The interventions under investigation include: Placebo capsules (OTHER), Nutrafol Supplement capsules (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT03206567?

This trial is sponsored by Ablon Skin Institute Research Center, which has 7 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03206567 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hair Thinning

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.